Cargando…
Retracted: Knockdown of lncRNA HOXD-AS2 Improves the Prognosis of Glioma Patients by Inhibiting the Proliferation and Migration of Glioma Cells
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371619/ https://www.ncbi.nlm.nih.gov/pubmed/37501828 http://dx.doi.org/10.1155/2023/9859158 |
Ejemplares similares
-
Retracted: Identification of Prognostic LncRNAs Subtypes Predicts Prognosis and Immune Microenvironment for Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Correlations between Clinical Characteristics and Prognosis in Patients with Grade II Glioma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: COQ10B Knockdown Modulates Cell Proliferation, Invasion, Migration, and Apoptosis in Esophageal Squamous Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Characterization of lncRNA-Based ceRNA Network and Potential Prognostic Hub Genes for Sepsis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)